PATHOCIL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Pathocil, and what generic alternatives are available?
Pathocil is a drug marketed by Wyeth Ayerst and is included in two NDAs.
The generic ingredient in PATHOCIL is dicloxacillin sodium. There are nine drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the dicloxacillin sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Pathocil
A generic version of PATHOCIL was approved as dicloxacillin sodium by TEVA on June 3rd, 1982.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PATHOCIL?
- What are the global sales for PATHOCIL?
- What is Average Wholesale Price for PATHOCIL?
Summary for PATHOCIL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 89 |
| Patent Applications: | 1,021 |
| DailyMed Link: | PATHOCIL at DailyMed |
US Patents and Regulatory Information for PATHOCIL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wyeth Ayerst | PATHOCIL | dicloxacillin sodium | CAPSULE;ORAL | 050011-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Wyeth Ayerst | PATHOCIL | dicloxacillin sodium | CAPSULE;ORAL | 050011-003 | Mar 28, 1983 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Wyeth Ayerst | PATHOCIL | dicloxacillin sodium | FOR SUSPENSION;ORAL | 050092-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
